1. Home/
  2. Compounds/
  3. erlotinib:PLX-4032 (2:1 mol/mol)

erlotinib:PLX-4032 (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2erlotinib:PLX-4032 (2:1 mol/mol)
PharmacoGx erlotinib:PLX-4032 (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to erlotinib:PLX-4032 (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA TACSTD2 CTRPv2 pan-cancer AAC 0.23 6e-07
mRNA PLAT CTRPv2 pan-cancer AAC 0.19 6e-07
mRNA MPZL2 CTRPv2 pan-cancer AAC 0.2 7e-07
mRNA ARL3 CTRPv2 pan-cancer AAC -0.2 8e-07
mRNA CH17-296N19.1 CTRPv2 pan-cancer AAC 0.19 8e-07
mRNA FAM3C CTRPv2 pan-cancer AAC 0.2 9e-07
mRNA NIT2 CTRPv2 pan-cancer AAC 0.19 9e-07
mRNA STK3 CTRPv2 pan-cancer AAC 0.2 9e-07
mRNA GIPC1 CTRPv2 pan-cancer AAC 0.22 1e-06
mRNA SEMA3B CTRPv2 pan-cancer AAC 0.19 1e-06
Download CSV